Literature DB >> 22472778

MicroRNAs in autoimmune rheumatic diseases.

M Galeazzi1, E Balistreri, C Giannitti, G D Sebastiani.   

Abstract

The etiology of autoimmune diseases remains largely unknown. In recent years, besides genetic factors, several studies proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically epigenetic regulatory mechanisms comprise DNA methylation, a variety of histone modifications, and microRNA (miRNA) activity, all of which act upon gene and protein expression levels. In particular it is well known that epigenetic mechanisms are important for controlling the pattern of gene expression during development, the cell cycle, and the response to biological or environmental changes. In the present review a description of the most frequent epigenetic deregulations, in particular the role of miRNAs, in rheumatic autoimmune disorders will be investigated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472778     DOI: 10.4081/reumatismo.2012.7

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  3 in total

Review 1.  MicroRNA-155 as a therapeutic target for inflammatory diseases.

Authors:  Naghmana Kanwal; Peter John; Attya Bhatti
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

2.  Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A.

Authors:  Silvia Spena; Andrea Cairo; Emanuela Pappalardo; Marcin M Gorski; Isabella Garagiola; Shermarke Hassan; Roberta Gualtierotti; Flora Peyvandi
Journal:  Haemophilia       Date:  2022-02-19       Impact factor: 4.263

3.  The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies.

Authors:  Martina Remakova; Tana Svitalkova; Marek Skoda; Jiri Vencovsky; Peter Novota
Journal:  F1000Res       Date:  2013-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.